Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 42.18M P/E - EPS this Y -2.50% Ern Qtrly Grth -
Income -37.57M Forward P/E -1.49 EPS next Y 8.10% 50D Avg Chg 12.00%
Sales 9.14M PEG - EPS past 5Y - 200D Avg Chg -38.00%
Dividend N/A Price/Book 0.38 EPS next 5Y - 52W High Chg -81.00%
Recommedations 3.00 Quick Ratio 8.56 Shares Outstanding 31.91M 52W Low Chg 41.00%
Insider Own 5.40% ROA -25.00% Shares Float 30.19M Beta -0.86
Inst Own 14.74% ROE -42.73% Shares Shorted/Prior 225.78K/300.94K Price 1.37
Gross Margin 59.83% Profit Margin - Avg. Volume 126,853 Target Price 1.50
Oper. Margin -289.06% Earnings Date Nov 7 Volume 71,981 Change -2.49%
About Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Co-Diagnostics, Inc. News
11/10/24 Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations
11/08/24 Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline and ...
11/07/24 Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
11/05/24 Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024
10/31/24 Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans?
10/25/24 Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast
08:30 AM Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024
10/10/24 Alignment HealthCare Partners With Intermountain Health in Nevada
10/09/24 Co-Diagnostics Inc (CODX) Q2 2024 Earnings Call Highlights: Revenue Surge Amidst Regulatory Hurdles
10/02/24 Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3
09/24/24 Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan
09/05/24 Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test
08/27/24 Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?
08/15/24 Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.
08/11/24 Co-Diagnostics Second Quarter 2024 Earnings: Beats Expectations
08/08/24 Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results
07/29/24 Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago
07/25/24 Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast
07/02/24 Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States
06/18/24 Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
CODX Chatroom

User Image Millones Posted - 7 minutes from now

$CODX November 21st, 2024 MPOX https://www.theguardian.com/commentisfree/2024/nov/21/world-responded-slowly-mpox-outbreak

User Image My_Lai_1968 Posted - 47 minutes ago

$CODX My cousin's live-in girlfriend, who owns 1 hamster, 3 goldfish and 1 mentally ill parakeet, just texted me that her stock charting techniques show CODX rising to $27/per share by February 17. I texted back that I was grateful for her due diligence on CODX and I also asked how the poor parakeet was doing. She said he was in psychotherapy at the moment because lately he has been making "Tweety Bird" sounds in Portuguese.

User Image WhoElseButQuagmire Posted - 1 hour ago

$CODX Ok wife was terminated from her job. It’s a blessing anyways the way they treat their employees. Scumbag management. Now this can please pop? Dip before the rip?

User Image Atomsrus Posted - 1 hour ago

$CODX https://studyfinds.org/bird-flu-mutations/

User Image Atomsrus Posted - 2 hours ago

$CODX https://www.the-sun.com/health/12939886/bird-flu-pandemic-mutate-human-canada/

User Image Millones Posted - 2 hours ago

$CODX Another day trading full vertical :)

User Image Millones Posted - 2 hours ago

$CODX 14 more @ $1.04 33 more @ 1.03 Little at a time my friends. I don’t want to spook the boogeyman, or potentially miss the bottom. Been buying for under cash value for years not months. Tomorrow I’ll buy more. Not financial advice. Warchest is heavy. Inauguration of 2 new manufacturing facilities in USA and India in 2024 along with 2 FDA submissions in 12 months. Plus they received another CDSCO (India equivalent of FDA) approval for multiplex PCR test in 2024 to add to the growing list of already 15+ IVD approvals in India. Even if USA decides we aren’t good enough, it seems like India is a fan of the CoPrimers. Time will tell. Buying and holding for now. GLTYA, NFA! 🧬 🧮 🕰️ ™️ 🔜 🚀

User Image Minutiae Posted - 12 hours ago

$CODX Nov 20 CODX short volume 21% out of a 129,404 trade volume closing at $1.04. 211 after-hour shares traded at $1.04.

User Image usedCODX Posted - 14 hours ago

$CODX 👀 save the world Dwight! https://x.com/COVID19_disease/status/1859097650529808735?t=aD8cowDixqd4vg3dSDGmsQ&s=19

User Image wasserschlag10 Posted - 15 hours ago

$CODX At 0,50 $/share I will buy big !!

User Image Bremtrader Posted - 1 day ago

$CODX we normally bounced back from the 1$ range. Lets see. FDA could help a little 😉

User Image skiphil Posted - 1 day ago

$CODX "$CODX Perspective on valuation: Sept. 2013 BioMerieux acquires BioFire for $450mm + $35mm of net debt (ie. $485mm enterprise value). They took out $450mm of debt to finance the purchase, so realistically they paid ~115% of the purchase price when factoring capital structure. FilmArray, the motive for the acquisition, was expected to generate $40mm in revenue that year and BioFire was expected to lose $(25)mm. FilmArray platform was to be used in hospital labs+CLIA labs and had two tests: sepsis (FDA approved June '13) & respiratory multiplex (FDA & CE approved March '21 ). Respiratory test took 1hr to run. " The difference is, The FilmArray... 1. Already had FDA approval for a wide variety of tests. 2. Was already on the market. 3. Was unmatched in ease of use and accuracy. 4. Most importantly... Actually worked. BioMerieux made back their $485mm before Covid even hit. Then they made billions more off that acquisition. There has been no published example of the CODX device working.

User Image Bremtrader Posted - 1 day ago

$CODX bought 500 today…

User Image Taylor1278 Posted - 1 day ago

$CODX nice splash of volume on the open!

User Image Millones Posted - 1 day ago

$CODX 44,444 shares traded so far…

User Image Minutiae Posted - 1 day ago

$CODX 🎪 RFK Jr. in the Land of Dr. Oz 🎢 HHS Organizational Charts Office of Secretary and Divisions Content last reviewed November 19, 2024 "Select an office to see its organizational chart." https://www.hhs.gov/about/agencies/orgchart/index.html

User Image Minutiae Posted - 1 day ago

$CODX Nov 19 CODX short volume 21% out of a 62,843 trade volume closing at $1.07. 309 after-hours shares traded at $1.06 to $1.10.

User Image Atomsrus Posted - 1 day ago

$CODX https://www.miamiherald.com/news/health-care/article295787254.html

User Image Atomsrus Posted - 1 day ago

$CODX https://www.sciencealert.com/human-cases-of-bird-flu-confirmed-to-be-occurring-undetected-in-the-us

User Image Atomsrus Posted - 1 day ago

$CODX https://www.theguardian.com/world/2024/nov/19/bird-flu-cases-mutation-canada

User Image ccx Posted - 1 day ago

$CODX Perspective on valuation: Sept. 2013 BioMerieux acquires BioFire for $450mm + $35mm of net debt (ie. $485mm enterprise value). They took out $450mm of debt to finance the purchase, so realistically they paid ~115% of the purchase price when factoring capital structure. FilmArray, the motive for the acquisition, was expected to generate $40mm in revenue that year and BioFire was expected to lose $(25)mm. FilmArray platform was to be used in hospital labs+CLIA labs and had two tests: sepsis (FDA approved June '13) & respiratory multiplex (FDA & CE approved March '21 ). Respiratory test took 1hr to run. CoDx current Enterprise Value is $0.

User Image Ruddogg21 Posted - 1 day ago

$CODX I might be invited to India with my current Sharehold 🤑🤑🤑

User Image Millones Posted - 1 day ago

$CODX Company is ready “if such a need arises”… November 2024 https://www.kron4.com/news/bay-area/east-bay-child-tests-positive-for-bird-flu/amp/ March 2024 https://ir.co-dx.com/2024-03-07-Co-Diagnostics,-Inc-JV-CoSara-Receives-Clearance-from-Indian-Regulators-for-Influenza-Multiplex-PCR-Test

User Image diamondhope Posted - 2 days ago

$CODX imo What would be the reason to sell today, seems illogical? But who thinks we might hear something on Thursday?

User Image Millones Posted - 2 days ago

$CODX 🚨 Co Diagnostics stock price experiences near vertical price appreciation. 🚀

User Image Atomsrus Posted - 2 days ago

$CODX they wont fill my order. Hmmmm

User Image Ruddogg21 Posted - 2 days ago

$CODX Overdue for Green Candles LETS GO!!!!!!!!

User Image Millones Posted - 2 days ago

$CODX Down on the 1D, 1W, 1M, 3M, 6M 1Y, ALL Cool cool cool Retested the triple bottom yesterday. I still think this is a dormant volcano. Locked up more shares today, will buy more tomorrow. Doesn’t matter where the price goes until we receive word from FDA. FDA EUA submitted 11 months ago FDA 510(k) submitted 5 months ago I’m very curious about this EUL MPOX application with the WHO and if they will decide to pursue it. I don’t see it giving us much in terms of baseline revenues, but a little extra exposure can’t hurt. Company has given us plenty of opportunities to acquire shares on the cheap. I remember the times of every other day PR. I think they are building the machine again to hammer the wires once appropriate. Dwight has done this before with CBS Market watch. Richard Abbott as the second in command has also done this before as the VP of engineering at BioFire. Learning from his MBA from Wharton (world’s oldest business collegiate). Science. Mathematics. Patience.

User Image SmallPhish Posted - 2 days ago

$CODX MMs somehow know this is the week of FDA approval?

User Image Millones Posted - 2 days ago

$CODX CoPrimers

Analyst Ratings
HC Wainwright & Co. Neutral Aug 12, 24
HC Wainwright & Co. Neutral Jun 17, 24
HC Wainwright & Co. Neutral May 13, 24
HC Wainwright & Co. Neutral Mar 15, 24
HC Wainwright & Co. Neutral Dec 29, 23
HC Wainwright & Co. Neutral Nov 13, 23
HC Wainwright & Co. Neutral Aug 14, 23
HC Wainwright & Co. Neutral May 15, 23
HC Wainwright & Co. Neutral Mar 20, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Brown Brian Lee Chief Financial Offi.. Chief Financial Officer Mar 20 Buy 1.899 3,000 5,697 76,236 03/21/23
Egan Dwight H Chief Executive Offi.. Chief Executive Officer Jan 20 Option 2.63 50,000 131,500 50,000 01/20/21
Egan Dwight H Chief Executive Offi.. Chief Executive Officer Jan 20 Sell 11 38,046 418,506 01/20/21
Egan Dwight H Chief Executive Offi.. Chief Executive Officer Nov 25 Option 1.1 150,000 165,000 50,000 11/25/20
Egan Dwight H Chief Executive Offi.. Chief Executive Officer Nov 25 Sell 10.68 134,350 1,434,858 11/25/20